Role of apolipoprotein E in renal damage protection (Q45083057)

9 December 2017

Role of apolipoprotein E in renal damage protection (English)

1 reference

9 December 2017

1

1 reference

9 December 2017

Luigi Fabrizio Rodella

2

1 reference

9 December 2017

M Moghadasian

3

1 reference

9 December 2017

C Lonati

4

1 reference

9 December 2017

R Coleman

5

1 reference

9 December 2017

R Rezzani

6

1 reference

9 December 2017

15 May 2011

1 reference

Histochemistry and Cell Biology

9 December 2017

1 reference

9 December 2017

135

1 reference

9 December 2017

6

1 reference

9 December 2017

571-579

1 reference

https://scigraph.springernature.com/pub.10.1007/s00418-011-0815-1

9 December 2017

0 references

cites work

Cellular lipid metabolism and the role of lipids in progressive renal disease

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Apolipoprotein E synthesis in human kidney, adrenal gland, and liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Mesangial expansion associated with glomerular endothelial cell activation and macrophage recruitment is developing in hyperlipidaemic apoE null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Dyslipidemia and the progression of renal disease in chronic renal failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

A protective role for kidney apolipoprotein E. Regulation of mesangial cell proliferation and matrix expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

The effect of lipoproteins on the development and progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Aging, telomeres, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Workshop: excess growth and apoptosis: is hypertension a case of accelerated aging of cardiovascular cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Immunomodulation of atherosclerosis: myth and reality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Perlecan mediates the antiproliferative effect of apolipoprotein E on smooth muscle cells. An underlying mechanism for the modulation of smooth muscle cell growth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Regulation of filtration rate by glomerular mesangial cells in health and diabetic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Modulation of antioxidant enzyme expression and function by estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Lower antioxidant capacity and elevated p53 and p21 may be a link between gender disparity in renal telomere shortening, albuminuria, and longevity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Telomeres and replicative senescence: Is it only length that counts?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Oxidative stress shortens telomeres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Telomeres as biomarkers for ageing and age-related diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

Association of Apolipoprotein 2 Allele With Diabetic Nephropathy in Caucasian Subjects With IDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-011-0815-1

APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies

21 January 2018

1 reference

12 December 2020

Role of oxidative stress in telomere length regulation and replicative senescence

1 reference

12 December 2020

Apolipoprotein E genotypes and risk of diabetic nephropathy

1 reference

12 December 2020

Lipoprotein and receptor interactions in vivo.

1 reference

12 December 2020

ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree

1 reference

12 December 2020

Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E

1 reference

12 December 2020

Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy

1 reference

12 December 2020

Mesangial cell injury, glomerulosclerosis, and therapeutic intervention

1 reference

12 December 2020

Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components

1 reference

12 December 2020

Renal injury in apolipoprotein E-deficient mice

1 reference

12 December 2020

Type III hyperlipoproteinemia associated with apolipoprotein E deficiency

1 reference

12 December 2020

Volume-weighted mean glomerular volume in spontaneously hypertensive rats treated with different doses of spironolactone

1 reference

12 December 2020

Functional and morphometric evaluation of offspring kidney after intrauterine undernutrition

1 reference

12 December 2020

Apolipoprotein E and its role in aging and survival

1 reference

12 December 2020

10.1007/S00418-011-0815-1

Identifiers

DOI

1 reference

Dimensions Publication ID

9 December 2017

0 references

1 reference